ClinicalTrialsFinder
RecruitingNot ApplicableNCT05292521

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

Utilizing Patient Reported Quality of Life to Inform Patient Decision Making in Early-Stage Lung Cancer

Sponsor

Roswell Park Cancer Institute

Enrollment

150 participants

Start Date

Dec 21, 2023

Study Type

INTERVENTIONAL

Conditions

Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8

Summary

This clinical trial studies the effect of a quality of life intervention on decision-making in patients with early-stage lung cancer who are undergoing standard of care surgery or stereotactic body radiation therapy (SBRT). Providing quality of life outcome data to patients deciding between surgery and SBRT may help decrease decision regret and increase patient satisfaction with their care.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study helps early-stage lung cancer patients make better treatment decisions by giving them information about quality of life before they choose between surgery and a type of targeted radiation called SBRT (stereotactic body radiation therapy). **You may be eligible if...** - You are 18 or older - You have been diagnosed with stage I or II non-small cell lung cancer (NSCLC) - You are a candidate for both surgery AND SBRT radiation - You can communicate in English **You may NOT be eligible if...** - Your lung cancer is stage III or IV - You are only eligible for one treatment option (surgery OR radiation, but not both) - You cannot understand or communicate in English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBest Practice

Receive usual care

OTHERInformational Intervention

Receive QOL fact sheet

OTHERQuestionnaire Administration

Ancillary studies

Locations(1)

Roswell Park Cancer Institute

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05292521

Related Trials

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT042678481149 locations

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

NCT06498635227 locations

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

NCT073236411 location

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial

NCT047896811 location

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

NCT0728803413 locations